BPR1K871 (C007B-589228)

InformationBPR1K871 (DBPR114) is a potent and selective dual inhibitor of FLT3 and AURKA with IC50 of 19 nM and 22 nM, respectively. BPR1K871 (DBPR114) acts as a preclinical development candidate for anti-cancer therapy.

Specification: Moligand™, ≥97%

Molecular Formula: C25H28ClN7O2S

Molecular Weight: 526.1

PubChem CID: 126970666

Isomeric SMILES: CN(C)CCCOC1=CC2=C(C=C1)C(=NC=N2)NCCC3=CN=C(S3)NC(=O)NC4=CC(=CC=C4)Cl

UPC:

51434955

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

B412579-100mg

Product Size:

100mg

CAS:

2443767-35-7